Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 2,355: | Line 2,355: | ||
| | | | ||
| | | | ||
|- | |||
|}<br /> | |||
==WHO Classification of Tumours of Breast Tumours Content== | |||
{| class="wikitable" | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete | |||
| | |||
|Fabiola Quintero-Rivera (FQR) | |||
|Date page was created | |||
| | |||
|- | |||
| Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease | |||
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete | |||
|- | |- | ||
|}<br /> | |}<br /> | ||